Prestige Consumer Healthcare Inc
PBH74.302USD
+0.582+0.79%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
3.68BCap. mercado
17.14P/E TTM
Más Datos de Prestige Consumer Healthcare Inc Compañía
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Información de la empresa
Símbolo de cotizaciónPBH
Nombre de la empresaPrestige Consumer Healthcare Inc
Fecha de salida a bolsaFeb 10, 2005
Director ejecutivoMr. Ronald M. (Ron) Lombardi, CPA
Número de empleados600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 10
Dirección660 White Plains Rd.
CiudadTARRYTOWN
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal10591
Teléfono19145246800
Sitio Webhttps://www.prestigebrands.com/
Símbolo de cotizaciónPBH
Fecha de salida a bolsaFeb 10, 2005
Director ejecutivoMr. Ronald M. (Ron) Lombardi, CPA
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
50.30K
+0.19%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
25.83K
+0.36%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
12.24K
+0.77%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
9.23K
+1.02%
Mr. John F. Kelly
Mr. John F. Kelly
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
50.30K
+0.19%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
25.83K
+0.36%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.76%
The Vanguard Group, Inc.
11.42%
Dimensional Fund Advisors, L.P.
5.52%
Ariel Investments, LLC
5.12%
Macquarie Investment Management
4.58%
Other
58.60%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.76%
The Vanguard Group, Inc.
11.42%
Dimensional Fund Advisors, L.P.
5.52%
Ariel Investments, LLC
5.12%
Macquarie Investment Management
4.58%
Other
58.60%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
66.48%
Investment Advisor/Hedge Fund
33.15%
Research Firm
3.01%
Hedge Fund
1.59%
Pension Fund
1.35%
Individual Investor
1.26%
Sovereign Wealth Fund
1.09%
Family Office
0.82%
Bank and Trust
0.52%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
662
53.52M
108.70%
-2.21M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
2023Q1
593
52.66M
105.96%
-3.39M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
7.27M
14.76%
-220.73K
-2.95%
Mar 31, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-54.84K
-0.97%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.72M
5.52%
-190.35K
-6.55%
Mar 31, 2025
Ariel Investments, LLC
2.52M
5.12%
-243.08K
-8.80%
Mar 31, 2025
Macquarie Investment Management
2.25M
4.58%
-56.53K
-2.45%
Mar 31, 2025
State Street Global Advisors (US)
2.00M
4.06%
-65.72K
-3.18%
Mar 31, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.58M
3.21%
+493.20K
+45.35%
Mar 31, 2025
Allspring Global Investments, LLC
1.62M
3.28%
-8.51K
-0.52%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.40M
2.85%
+54.84K
+4.07%
Mar 31, 2025
Victory Capital Management Inc.
1.14M
2.32%
-519.07K
-31.22%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Pharmaceuticals ETF
3.59%
Invesco S&P SmallCap Health Care ETF
2.82%
Congress SMid Growth ETF
2.81%
Schwab Ariel Opportunities ETF
2.64%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.55%
Invesco Pharmaceuticals ETF
2.51%
iShares U.S. Pharmaceuticals ETF
1.98%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.36%
Brandes US Small-Mid Cap Value ETF
1.27%
ETC 6 Meridian Small Cap Equity ETF
1.04%
Ver más
SPDR S&P Pharmaceuticals ETF
Proporción3.59%
Invesco S&P SmallCap Health Care ETF
Proporción2.82%
Congress SMid Growth ETF
Proporción2.81%
Schwab Ariel Opportunities ETF
Proporción2.64%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción2.55%
Invesco Pharmaceuticals ETF
Proporción2.51%
iShares U.S. Pharmaceuticals ETF
Proporción1.98%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción1.36%
Brandes US Small-Mid Cap Value ETF
Proporción1.27%
ETC 6 Meridian Small Cap Equity ETF
Proporción1.04%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
